Related Quotes Sym. Price Chg. ADSX Trade News 1.6 0.19 DOC Trade News 2.51 -0.01 VeriChip Corporation Deploys VeriMed System in 18 Emergency Departments Through Emergency Medical Associates` Client Hospitals; Leading Physician Group To Utilize VeriMed System Throughout Hospitals in New York and New Jersey
September 20, 2006 09:16:29 (ET)
DELRAY BEACH, Fla., Sep 20, 2006 (BUSINESS WIRE) -- VeriChip Corporation, a subsidiary of Applied Digital Solutions (ADSX, Trade), announced today that it has deployed its VeriMed System in 18 emergency departments in New Jersey and New York, staffed by Emergency Medical Associates (EMA), a nationally-recognized, state-of-the-art emergency physician group.
The VeriMed System, which consists of a hand-held radio frequency identification (RFID) scanner, an implantable RFID microchip, and a secure patient database, is being used to help rapidly identify and provide access to important health information on participating patients who arrive at the emergency department unconscious, delirious, or unable to communicate. Although over 150 hospitals have registered to use the VeriMed System, EMA is the first emergency physician group in the United States to have the VeriMed System available in all 18 of its contract hospitals.
"VeriChip Corporation is extremely pleased that EMA, one of the country's leading emergency physician groups, with a history of being an innovator in healthcare technology, has partnered with its client hospitals to place the VeriMed System in their emergency departments as a best practice, for the communities they serve," said Kevin McLaughlin, CEO of VeriChip Corporation. "By speaking for patients who are unable to effectively communicate, we believe that the VeriMed System complements EMA's emergency department operations by providing emergency personnel with rapid, accurate information which can improve clinical outcomes."
Former Secretary of Health and Human Services Tommy Thompson, a VeriChip Corporation board member, stated, "The pending integration of the VeriMed System and EMA's state-of-the-art electronic medical record, known in the industry for over 17 years as the Emergency Department Information Manager, or EDIM (www.emis.net), offers emergency department staff access to time sensitive medical information simultaneously."
The EDIM electronic medical record system is currently used in over 24 emergency departments across the United States. It boasts the highest user compliance for utilization in the Emergency Department Information Systems software niche. Additionally, with over 8 million ED encounters in WebEMARS, its sophisticated data warehouse, Emergency Medical Associates is a recognized national leader in Health Care Business Intelligence.(TM)
"EMA's adoption of the VeriMed System was a natural fit in our ongoing commitment to being a leader in the adoption of new technology and best practices," said Charles "Rick" Grunau, MD, President and CEO of EMA. "EMA treats close to one million emergency department patients a year, so we are excited about the prospect of the VeriMed System helping us handle patients who are not able to communicate. We'll be monitoring the benefits, both operational and clinical, to assess its impact on care and outcomes," adds Dr. Grunau. "We look forward to partnering with VeriChip and our client hospitals to deploy the VeriMed readers in other applicable areas of the health care delivery system, where it can provide benefits to our patients and their families."
About VeriChip
VeriChip Corporation, a subsidiary of Applied Digital (ADSX, Trade), a leading provider of identification and security technology headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System, which is used to rapidly, and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
About Applied Digital - "The Power of Identification Technology"
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company's unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (DOC, Trade).
About EMA
Emergency Medical Associates (EMA) is a premier, democratically-governed emergency physician group, which has been providing state-of-the-art emergency care for over 28 years and ensuring the highest levels of clinical excellence and patient satisfaction. To find out additional information about EMA, please visit their website at www.ema-ed.com. To view information on their emergency department information systems (EDIM and WebEMARS), please go to www.edims.net.
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
SOURCE: VeriChip Corporation
Investors: CEOcast, Inc. Dan Schustack, 212-732-4300 dschustack*ceocast.com or Media: Direct Communications Group John O. Procter, 202-772-2179 jprocter*dcgpr.com
-------------------- LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT! Posts: 9276 | From: San Diego CA | Registered: Jul 2006
| IP: Logged |
posted
Related Quotes Sym. Price Chg. ADSX Trade News 1.6 0 DOC Trade News 2.58 0 VeriChip Corporation Announces Sale of VeriTrace(TM) System and 700 VeriChips and Inserters to the States of Florida And Hawaii
September 21, 2006 09:00:35 (ET)
DELRAY BEACH, Fla., Sep 21, 2006 (BUSINESS WIRE) -- VeriChip Corporation, a subsidiary of Applied Digital Solutions (ADSX, Trade), announced today that the State of Florida, through the Florida Emergency Mortuary Operations Response System (FEMORS), and the State of Hawaii Department of Health, have each purchased the VeriTrace system for disaster relief and emergency management needs.
The VeriTrace system was created in the immediate aftermath of Hurricane Katrina. The VeriTrace System proved helpful in identifying, tracking and accounting for the remains of victims from the hurricane. According to Gary Hargrove, Coroner in charge of the Disaster Mortuary Operational Response Team (DMORT), Harrison County, Mississippi, "Shortly after Hurricane Katrina struck the Mississippi Gulf Coast, employees of VeriChip Corporation arrived in Harrison County to provide assistance with the VeriTrace system. VeriTrace was used during the DMORT and recovery operations. The system greatly enhanced coordination between the tracking of the deceased and paperwork. The system was a great tool to use in the recovery, providing added safety to return the right deceased to the right family."
VeriTrace is designed to assist state and federal agencies to plan for and manage emergency situations and disaster recovery using implantable RFID technology. The VeriTrace system includes a unique implantable RFID microchip, a VeriTrace Bluetooth(TM) handheld reader, a customized Ricoh Caplio Pro G3 Digital Camera capable of receiving both RFID scanned data and GPS data wirelessly, and a Web-enabled database for gathering and storing information and images captured during emergency response operations. This database ensures the precise collection, storage and inventory of all data and images related to remains and the associated evidentiary items. This also allows the creation of an accurate and complete reconstruction of a disaster setting, crime scene or similar environment and location, where necessary or appropriate.
VeriTrace is the only end-to-end solution to use implantable RFID tags for such a purpose. The VeriTrace system is also the first identification and tracking modality to automatically record each tag's identification number along with the GPS coordinates captured by the Ricoh camera into the images, also captured by the Ricoh camera, during disaster response and recovery situations.
Marc Nishimoto, Planner, Office of Public Health Emergency Preparedness for the County of Maui, stated, "We ordered VeriTrace because we are the public health and emergency preparedness branch for the Department of Health for the State of Hawaii. In case of a major disaster or fatality, we will be able to have the resources and equipment necessary to efficiently identify bodies."
In addition to the purchases from the States of Florida and Hawaii, training has already been provided on the VeriTrace system to nearly 500 personnel from the Federal Emergency Management Agency (FEMA), Disaster Mortuary Operational Response Teams, the National Disaster Medical System (NDMS) and the Georgia Bureau of Investigation (GBI).
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System which is used to rapidly and accurately identify people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or email info*verichipcorp.com. Additional information can be found online at www.verichipcorp.com.
About Applied Digital - "The Power of Identification Technology"
Applied Digital is the parent company of VeriChip Corporation. Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. Through Applied Digital's affiliates, the company offers unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as a leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (DOC, Trade).
Statements about Applied Digital's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and Applied Digital's actual results could differ materially from expected results. The company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
posted
Related Quotes Sym. Price Chg. ADSX Trade News 1.58 0 DOC Trade News 2.52 0 Digital Angel Targets $100 Million Equine Market; California Has Ordered 4,000 Bio-Thermo Chips for Horses; 500 Chips Already Implanted; Company Plans to Launch National Marketing Effort
September 25, 2006 08:30:24 (ET)
SO. ST. PAUL, Minn., Sep 25, 2006 (BUSINESS WIRE) -- Following strong demand for its Bio-Thermo(TM) chip in California and a successful regional marketing program, Digital Angel Corporation (DOC, Trade) today announced an aggressive national initiative to target the more than $100 million equine market for identification products with its patented, temperature-sensing implantable microchip.
The product, Bio-Thermo(TM), will provide approximately 8 million horses in the United States with a unique identification and health status surveillance required by local and state equine animal health professionals. Digital Angel, which specializes in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets, is in discussions with several large distributors.
"This is a major development for Digital Angel. The early results of our current program in Southern California have been overwhelmingly positive. Since late last year the California Horseracing Board, a division of the California Department of Agriculture, has been using federal funds to implant all new, in-coming young horses entering their racing career, with the Digital Angel Bio-Thermo chips," said President and CEO Kevin N. McGrath. "To date, the California Horseracing Board has purchased 1,500 Bio-Thermo chips, out of an order of 4,000, and an estimated 500 horses at Southern California racetracks have already been successfully implanted."
According to the company, The New York State Horse Health Assurance Program recently implemented a comprehensive health campaign that utilizes Bio-Thermo chips, and other state agencies are expected to launch similar programs.
The bio-thermo microchip is about the size of a grain of rice. It is easily, and harmlessly, injected into the crest of a horse's neck. The chip monitors the horse's temperature, which is a good indicator of the animal's health. The chip also contains a unique identification number that, when activated by a scanner, can be connected to a database with the horse's documentation.
Digital Angel has made significant progress in its electronic tags for livestock segment, a critical growth area for the company. It expects to post record-breaking numbers by the end of September, anticipating sales of 1.9 million electronic RFID livestock in the first nine months of 2006, rapidly exceeding full-year 2005 sales. Additionally, the U.S. Department of Agriculture named Digital Angel the first animal tag manufacturer in the government-sponsored National Animal Identification System program, underscoring the company's leadership position in the market.
"In bringing this new heat-sensing technology to the robust equine market, we are building from our leadership position in implantable tracking devices for livestock, pets and fish," said McGrath. "We are confident that nearly every horse in the United States can benefit from our Bio-thermo microchips, which will provide proper documentation, monitoring for infectious diseases, and preventing theft."
The announcement of the national equine chipping program reinforces the company's commitment to expand revenues and drive shareholder and market value. Digital Angel is already marketing the Bio-Thermo chip in the companion pet markets in the United Kingdom and Japan.
About Digital Angel Corporation
Digital Angel Corporation (www.DigitalAngelCorp.com) develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (ADSX, Trade).
The statements in this press release that are not strictly historical, are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to be covered by the safe harbors created by these sections. The forward-looking statements are subject to risks and uncertainties and the actual results that the Company achieves may differ materially from these forward-looking statements due to such risks and uncertainties, including, but not limited to, that Applied Digital Inc. owns 55.4% of the Company's common stock, that new accounting pronouncements regarding expensing of share based compensation may impact the Company's future results of operations, the Company may continue to incur net losses, infringement by third parties on the Company's intellectual property or development of substantially equivalent proprietary technology by the Company's competitors could negatively impact the Company's business, domestic and foreign government regulation and other factors could impair the Company's ability to develop and sell its products in certain markets, the Company relies on sales to government contractors for its animal identification and search and rescue beacon products, and any decline in the demand by these customers for such products could negatively affect the Company's business, the Company depends on a single production arrangement for its patented syringe-injectable microchips, and the loss of or any significant reduction in the production could have an adverse effect on the Company's business, technological change could cause the Company's products to become obsolete, the loss of one of the Company's principal customers could negatively impact the Company's net revenue, the Company's earnings will decline if the Company writes off goodwill and other intangible assets, options and warrants outstanding and available for issuance may adversely affect the market price of the Company's common stock, currency exchange rate fluctuations could have an adverse effect on the Company's sales and financial results, the Company depends on a small team of senior management. A detailed statement of risks and uncertainties is contained in the Company's reports to the Securities and Exchange Commission, including in particular the Company's Form 10-K for the fiscal year ended December 31, 2005. Investors and stockholders are urged to read this document carefully. The Company can offer no assurances that any projections, assumptions or forecasts made or discussed in this release will be met, and investors should understand the risks of investing solely due to such projections. The Company undertakes no obligation to revise any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
